donepezil orion õhukese polümeerikattega tablett
orion corporation - donepesiil - õhukese polümeerikattega tablett - 5mg 98tk; 5mg 56tk; 5mg 28tk
ambrolytin siirup
sopharma ad - ambroksool - siirup - 3mg 1ml 100ml 1tk
muse 250mcg uretraalpulk
meda ab - alprostadiil - uretraalpulk - 250mcg 1tk; 250mcg 6tk
lipanthyl kõvakapsel
viatris sia - fenofibraat - kõvakapsel - 200mg 30tk
brexin suukaudse lahuse pulber
chiesi pharmaceuticals gmbh - piroksikaam - suukaudse lahuse pulber - 20mg 20tk
estrofem õhukese polümeerikattega tablett
first pharma oÜ - östradiool - õhukese polümeerikattega tablett - 2mg 28tk
rabeprazole doc generici gastroresistentne tablett
doc generici s.r.l. - rabeprasool - gastroresistentne tablett - 10mg 56tk; 10mg 28tk
brexin tablett
chiesi pharmaceuticals gmbh - piroksikaam - tablett - 20mg 20tk
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - rinnanäärmed - antineoplastilised ained - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.
zlynda õhukese polümeerikattega tablett
exeltis baltics uab - drospirenoon - õhukese polümeerikattega tablett - 4mg 168tk; 4mg 84tk; 4mg 28tk; 4mg 364tk